Good News for patients of Thalassemia

Chinese Group Develops Multicolor Melt Curve Test for Non-Deletional Alpha-Thalassemia Mutations. In an ethically charged first, Chinese researchers have used gene editing to modify human embryos obtained from an in vitro fertilization clinic. The 16-person scientific team, based at the Sun Yat-Sen University in Guangzhou, China, set out to see whether it could correct the gene defect that causes beta-thalassemia, a blood disease, by editing the DNA of fertilized eggs. The team’s report...

Read More